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Objective. To describe the experience of a tertiary center in Brazil to which patients are referred whose fetuses are at increased risk
for congenital heart diseases (CHDs).Methods.This was a cross-sectional observational study.The data was collected prospectively,
during the year 2012, through a screening protocol of the fetal heart adapted from the International Society of Ultrasound in
Obstetrics and Gynecology (ISUOG) guideline. We performed a fetal echocardiogram screening for all pregnant women who
were referred to the fetal cardiology outpatient obstetrics clinic of a university hospital. The exams were classified as normal or
abnormal.The cases considered abnormal were undergone to a postnatal echocardiogram.We categorized the abnormal fetal heart
according to severity in “complex,” “significant,” “minor,” and “others.”Results.Weperformed 271 fetal heart screening.The incidence
of abnormal screenings was 9.96% (27 fetuses). The structural CHD when categorized due to severity showed 48.1% (𝑛 = 13) of
“complex” cases, 18.5% (𝑛 = 5) “significant” cases, and 7.4% (𝑛 = 2) “minor” cases. The most common referral reason was by
maternal causes (67%) followed by fetal causes (33%).Themain referral indication was maternal metabolic disease (30%), but there
was just one fetus with CHD in such cases (1.2%). CHDs were found in 19/29 fetuses with suspicion of some cardiac abnormality by
obstetrician (65.5%).Conclusion. We observed a high rate of CHD in our population.We also found that there was higher incidence
of complex cases.
1. Introduction
Congenital heart diseases (CHDs) are the most common
abnormalities in fetuses, being six times more common than
chromosomal abnormalities and four times more common
than neural tube defects [1]. The incidence of CHD with
intrauterine diagnosis ranges from 2.4% to 54% [2–7]. Some
countries have high incidence of CHD because they have
instituted an organized policy to perform heart screening by
ultrasound systematically [8–10].
A detail evaluation of the fetal heart optimizes the diag-
nosis of CHD [11]. This provides an appropriate prenatal and
postnatal planning, enabling an improvement in neonatal
morbidity and surgical outcome [1, 12–15]. Therefore, there
is an increasing interest in improving detection of the cardiac
defects.
There are many epidemiological and ultrasonographic
data reported [2–7]; however, to the best of our knowledge,
there are no published Brazilian epidemiological data. Our
aim is to describe the experience of a tertiary center in Brazil
to which patients are referred whose fetuses are at increased
risk for CHD. After knowing the epidemiological features of
our population, we may improve the future screening and
treatment of CHD.
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2. Methods
This was a cross-sectional observational study. The data
was collected prospectively during the year of 2012, by a
screening protocol of the fetal heart adapted from the Inter-
national Society of Ultrasound in Obstetrics and Gynecology
(ISUOG) guideline [10, 16].
The study population was pregnant women who were
referred for prenatal assessment for suspicion or with some
risk of CHD. The exams were performed in the Fetal Cardi-
ology Unit, Department of Obstetrics, Federal University of
São Paulo (UNIFESP), which is a tertiary referral center in
Brazil. We recorded the indications of fetal heart screening,
maternal and gestational age, fetal heart screening findings,
and extracardiac abnormalities.
Fetal hearts were examined by two-dimensional, pulsed,
wave and color Doppler echocardiographic methods using
the Voluson E8 machine (General Electric, Medical System,
Zipf, Austria) equipped with a convex transducer (RAB
4-8L). All exams included a two-dimensional evaluation of
cardiac structures with the “basic” (four-chamber view of
the fetal heart) and the “extended basic” cardiac screening
examination (views of the outflow tracts) [10, 16].We also per-
formed the ductal and aortic arches position and we used the
color Doppler. We assessed the cardiac situs, rhythm, venous
inflow, atrial and ventricular chambers, atrioventricular and
semilunar valves, and ventriculoarterial connections [10, 16].
According to our protocol, the exams were classified as
“normal” or “abnormal.” The cases considered “abnormal”
were undergone to a postnatal echocardiogram at the same
hospital. We categorized the abnormal fetal heart according
to complexity of the heart anatomical abnormalities in “com-
plex,” “significant,” “minor,” and “others” (Table 1) [17, 18].
The data were entered into a specific protocol and were
transferred to a spreadsheet within the Excel 2007 soft-
ware (Microsoft Corp., Redmond, WA, USA). The statistical
analysis was realized using the Stata software version 12.1
(StataCorp LP, College Station, TX, USA).We performed Chi
Pearson and Exact Fisher tests for categorized variable and
Mann-Whitney test for quantitative variable. We used the
significance level of 𝑃 < 0.05.
3. Results
We performed heart screening in 271 fetuses during a period
of one year, of which, 27 fetuses had CHD (9.96%). All
patients were similar except for indication of screening
(Table 2), because the most common referral reason was
by maternal causes (67%) followed by fetal causes (33%).
Maternal causes for referral were advanced maternal age,
preexisting metabolic disease, exposure to teratogens rate,
maternal infection, and family history of CHDs. Fetal causes
for referral were abnormal sonographic findings during
routine assessment (increased nuchal translucency thickness,
extracardiac defects, or suspicion of cardiac abnormalities)
(Table 3).
The main referral indication was maternal metabolic
disease (30%), but there was just one fetus with CHD in such













Figure 1: Congenital heart disease categorized by severity: complex,
significant, minor, and others.
of some cardiac abnormality by obstetrician (65.5%). Then,
referral indications for fetal heart screening were appropriate
in cases where obstetricians suspected CHD (Table 3).
We identified 48.1% (𝑛 = 13) complex cases, 18.5% (𝑛 = 5)
significant cases, 7.4% (𝑛 = 2) minor cardiac anomalies, and
26% (𝑛 = 7) others. Others cases were dysrhythmia (com-
plete atrioventricular dissociation), hypertrophy myocardial,
dextroposition secondary, and ductus arteriosus restrictive
(Figure 1 and Table 4).
All CHD cases with prenatal diagnosis were submitted
to a postnatal echocardiogram at the same hospital to testify
the diagnosis. The mortality in one month was high (47.3%),
probably becausewe hadmany complex and significant cases.
4. Discussion
This study showed that the incidence of CHD in fetuses
(9.9%) corroborates with the findings of the literature [2–7, 9]
and this is our major contribution. The prenatal incidence of
CHD has a great variability ranging from 2.4% to 54%. This
variability depends on the performing of a systematic screen-
ing in each country. Published Brazilian epidemiological data
consider just the prevalence of CHDs in children [19–21] and
lack any data of prenatal incidence.
Regarding the referral indications for fetal heart screen-
ing, the maternal metabolic disease was greater than all
the other risk factors (30%). This is in discordance with
the literature that already reported a greater indication of
fetal heart screening for increased nuchal translucency [6],
intrauterine fetal death in previous pregnancy [3], finding
abnormal prenatal sonographic [22, 23], and family history
of a child with CHD [24].
We observed that the indications for fetal heart screening
were appropriate in cases where obstetricians suspected CHD
(65.5% with CHD). This demonstrates that our obstetricians
are accomplishing a good evaluation of the fetal heart;
however, wemust consider that this study was conducted in a
university hospital in our country and it does not portray the
reality of all obstetricians.
The complex and significant cases were more common
among CHD (66.6%). This finding suggests that in general
our cases are very severe which can justify the high mortality
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Table 1: Classification system of fetal heart diseases used according to complexity of the heart anatomical abnormalities.
Classification Fetal heart diseases
Complex
Heterotaxy or atrial isomerism, atresia or severe hypoplasia of a valve or chamber (hypoplastic left heart syndrome,
pulmonary atresia, tricuspid atresia, aortic atresia, mitral atresia, and Ebstein’s anomaly), and abnormalities of the valve
inlet or outlet (complete atrioventricular septal defect, truncus arteriosus, double inlet left or right ventricle, and double
outlet left or right ventricle congenitally corrected transposition of the great arteries)
Significant
Transposition of the great vessels, tetralogy of Fallot, large ventricular septal defect, coarctation of the aorta,
aortopulmonary window, critical aortic or pulmonary stenosis, partial atrioventricular septal defect, total anomalous
pulmonary venous connection, and tricuspid valve dysplasia (no Ebstein’s anomaly)
Minor Small ventricular septal defect and less severe aortic or pulmonary stenosis
Others Dysrhythmias, cardiomyopathies, secondary dextrocardia/levocardia, pulmonary sequestration, and restrictive ductusarteriosus
∗This classification was adapted from Hunter et al. [17] and Wren et al. [18].
Table 2: Baseline characteristics of the patients.
Normal heart (𝑛 = 244) Abnormal heart (𝑛 = 27) Total (𝑛 = 271) 𝑃
Maternal age at echo 0.17a
≥35 years old, 𝑛∘ (%) 103 (42%) 8 (29.6%) 111 (40.9%)
Gestation age at echo (weeks), mean (standard deviation) 27.8 (±4.6) 28.9 (±4.6) 27.8 (±4.6) 0.84b
Twin pregnancy, 𝑛∘ (%) 7 (2.8%) 1 (3.7%) 8 (2.9%) 0.58c
Race, 𝑛∘ (%) 0.07c
White 78 (45.4%) 8 (36.4%) 87 (44.6%)
Black 24 (13.9%) 1 (4.6%) 25 (12.8%)
Mixed 68 (39.5%) 11 (50%) 79 (40%)
Asian 2 (1.2%) 2 (9%) 4 (2%)
Indication of screening∗, 𝑛∘ (%) <0.001c
Maternal cause 180 (73%) 3 (11%) 183 (67%)
Fetus cause 66 (27%) 24 (89%) 90 (33%)
aChi Pearson test. bMann-Whitney test. cExact Fisher test. ∗Some cases had one more indication.
Table 3: Reasons for fetal heart screening and frequency of congenital heart disease.
Reasons for screening∗ Normal heart (𝑛 = 244) Abnormal heart (𝑛 = 27) Total (𝑛 = 271) CHD among referral reason
Maternal indications 180 3 183 (67%) 3/183 (1.6%)
Advanced maternal age (≥35 yo) 51 1 52 (19%) 1/52 (1.9%)
History of CHD 26 2 28 (10%) 2/28 (7.1%)
Preexisting metabolic disease 81 1 82 (30%) 1/82 (1.2%)
Infections 11 — 11 (4%) —
Teratogen exposure 4 — 4 (1.4%) —
Others 7 — 7 (2.5%) —
Fetal indications 66 24 90 (33%) 24/90 (26.7%)
Cardiac abnormality/dysrhythmia 10 19 29 (10.7%) 19/29 (65.5%)
Extracardiac abnormality 39 7 46 (17%) 7/46 (15%)
Central nervous system 25 3 28 (10.3%) 3/28 (10.7%)
Abdominal wall defect 2 1 3 (1%) 1/3 (33%)
Diaphragmatic hernia — 1 1 (0.4%) —
Functional renal agenesis 6 1 7 (2.5%) 1/7 (14%)
Others 6 1 7 (2%) —
Intrauterine growth restriction 3 — 3 (1%) —
Others 14 — 14 (5.1%) —
∗Some cases had one more indication. CDH: congenital heart disease; yo: years old.
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Table 4: Congenital heart disease recognised prenatally by classifi-
cation system of fetal heart diseases according to complexity of the
heart anatomical abnormalities.
Cardiac abnormality Frequency (𝑛 = 27)
Complex 13 (48.1%)
Heterotaxy or atrial isomerism 1




Complete atrioventricular septal defect 1
Double outlet of right ventricle 1
Significant 5 (18.5%)
Tetralogy of Fallot 2
Large ventricular septal defect 1
Tricuspid valve dysplasia 1
Critical pulmonary stenosis 1
Minor 2 (7.4%)






Restrictive ductus arteriosus 1
in our center. There are other researches about incidence of
CDH that show the same severity of heart disease [23, 24] and
its related to fatal cases.
We have some limitations regarding this study. First, we
had an absolute small number of abnormal cases in our
cohort which can prevent a more detailed statistic analyze.
Second, as this work was accomplished in a tertiary center, it
is difficult to generalize our data to other centers. However,
it can show a picture of the incidence of CHDs when the
screening is performed in a systematic way.
We observed a high rate of fetal heart disease in our
population. We also found, as expected, that there was a
higher incidence of complex cases. We recommend that
continuous efforts should be made for prenatal screening
program for CHD. We believe that with the knowledge of
these data we can improve the outcomes of morbidity and
mortality of children in our institution.
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